GPS Cancer™ test is a first-of-its-kind, comprehensive test offered by NantHealth. GPS Cancer integrates whole genome (DNA) sequencing, whole transcriptome (RNA) sequencing, and quantitative proteomics. GPS Cancer provides oncologists with a comprehensive molecular profile of a patient’s cancer to inform personalized treatment strategies, thereby helping to optimize patient care.*

Click here to learn more about GPS Cancer.